Project Grant D71TW013085

Award Date 5/5/25
Completion Date 2/28/27
Dollars Obligated $30K
Federal Grant Program
93.989
Assistance Type
Project Grant
Place of Performance
Enterprise Square, Corner of Front and, Nelson St, Monrovia, Liberia
Similar Awards
This Project Grant award from the National Institutes of Health (NIH) under the Trans-NIH Research Support program (CFDA 93.310) provides $205,235 to the University of North Carolina at Chapel Hill (UNC-CH) to conduct a combined microeconomic strengthening and stigma reduction intervention for young people with HIV in Zambia. The key products/services being delivered through this funding include: An 8-week program with two experimental components: (i) a stigma reduction support group providing...
This $153,912 Project Grant award from the National Institute of Allergy and Infectious Diseases (NIAID) under the Allergy and Infectious Diseases Research program (CFDA 93.855) supports a research study to examine the pharmacokinetics and pharmacogenomics of dolutegravir-based antiretroviral therapy in young people living with HIV in Ghana. The key objectives of the study are to: 1) Determine rates of dolutegravir-based antiretroviral therapy resistance in young people living with HIV; and 2)...
This $1,103,953 Project Grant award, funded by the National Institute on Aging (NIA) under CFDA 93.866 (Aging Research), supports a study to measure the epidemiology of cognitive impairment and dementia among people living with HIV in rural southwestern Uganda. The study will be conducted by Massachusetts General Hospital in collaboration with the Mbarara University of Science and Technology (MUST) and the Kabwohe Clinical Research Center (KCRC) in Uganda. Key products and services to be...
This $6,600,000 Cooperative Agreement was awarded by the U.S. Agency for International Development (USAID) under the USAID Foreign Assistance for Programs Overseas (CFDA 98.001) federal grant program. The award supports a 5-year project titled "HLT: NEW ACTIVITY - LHS ACTIVITY" to strengthen the health system in Liberia. The prime awardee, Management Sciences for Health, Inc. (MSH), will implement the project in collaboration with two sub-grantees - Public Health Initiative Liberia and...
The National Institute of Allergy and Infectious Diseases (NIAID) awarded a $381,487 Project Grant (CFDA 93.855 - Allergy and Infectious Diseases Research) to the University of Maryland, Baltimore (UMB) to assess the implementation and outcomes of introducing long-acting injectable cabotegravir (CAB-LA) pre-exposure prophylaxis (PrEP) among adolescent girls and young women at high risk of HIV acquisition in Zambia. The study, titled "Scaling Comprehensively Access to Long-Acting for...
This federal Project Grant award from the National Heart, Lung, and Blood Institute (NHLBI), under the Cardiovascular Diseases Research program (CFDA 93.837), provides $162,820 to New York University School of Medicine to conduct research aimed at developing a community-based strategy to link people living with HIV (PLWH) and comorbid hypertension to primary healthcare centers for hypertension management in Akwa Ibom, Nigeria. The key objectives of this 5-year project, titled "Leveraging...
This Project Grant award from the Fogarty International Center (CFDA 93.989), a program of the National Institutes of Health, provides $174,753 to Yale University to establish a registry of patients with HIV and rheumatic and musculoskeletal diseases (RMDs) in Uganda. The goal is to create a research and training platform to advance the understanding of the interplay between HIV and RMDs, which has been a significant but understudied challenge in sub-Saharan Africa. The project will leverage...
The National Institutes of Health's John E. Fogarty International Center (CFDA 93.989) awarded a $431,932 Project Grant (R21TW012967) to Yale University to adapt the PositiveLinks mHealth platform for improving HIV outcomes among older people with HIV in Ukraine. The project involves focus groups, usability testing, and a randomized controlled trial to evaluate the feasibility, acceptability, and efficacy of the adapted PositiveLinks Ukraine intervention in increasing viral load suppression, ART...
This federal Project Grant award of $685,637 from the National Institute of Child Health and Human Development (NICHD) under CFDA 93.865 - Child Health and Human Development Extramural Research aims to enhance research on inflammation and cognitive health among adolescents and young adults (AYA) living with perinatally acquired HIV (PHIV) and adversity in Uganda. The award supports a comprehensive study to investigate the relationship between immune dysfunction, inflammation, and...
This federal Project Grant award, funded by the National Institutes of Health (NIH) under the Child Health and Human Development Extramural Research program (CFDA 93.865), supports a comprehensive longitudinal study to assess the long-term immunologic, cardiovascular, metabolic, and neurocognitive outcomes in individuals with perinatal HIV exposure in Kenya. The $756,077 award, effective August 2024 through April 2029, aims to determine whether viral suppression on prolonged antiretroviral...

ADVANCING CLINICAL TRIALS ON HIV (ACTONHIV) IN LIBERIA - ADVANCING CLINICAL TRIALS ON HIV (ACTONHIV) IN LIBERIA PROJECT SUMMARY/ ABSTRACT HIV/AIDS IS ONE OF LIBERIA'S FOREMOST PUBLIC HEALTH CHALLENGES AND STILL CONTRIBUTES SIGNIFICANTLY TO THE COUNTRY'S MORBIDITY AND MORTALITY PROFILES. LIBERIA'S HIV RESPONSE INDICATORS FALL SIGNIFICANTLY SHORT OF THE UNAIDS 95-95- 95 TARGETS AND DATA FROM RECENT DEMOGRAPHIC AND HEALTH SURVEYS SHOW FORMIDABLE CHALLENGES TO ACHIEVING THOSE TARGETS INCLUDING LOW LEVELS OF COMPREHENSIVE KNOWLEDGE ABOUT HIV AND ITS ASSOCIATED RISK FACTORS, AS WELL AS HIV TESTING AMONG ITS POPULATION. FURTHERMORE, LIBERIA HAS YET TO ACHIEVE A SUFFICIENT WORKFORCE AND INFRASTRUCTURE TO SUPPORT OPTIMAL HIV SERVICE DELIVERY; AND FALLS SHORT OF THE MATURITY LEVEL, BASED ON THE WHO GLOBAL BENCHMARKING TOOL, TO INDEPENDENTLY SUPPORT HIGH-QUALITY HIV CLINICAL TRIALS AND THE REGULATORY SYSTEMS FOR DRUGS TO SUPPORT THEM AS WELL AS THE ABILITY TO CONDUCT RIGOROUS IMPLEMENTATION SCIENCE TO IMPROVE ITS HIV RESPONSE. THESE ARE PRIORITY GAPS THAT MUST BE ADDRESSED AS IT WILL HAVE PROFOUND IMPLICATIONS FOR HIV TREATMENT AND PREVENTION THAT ARE SUITABLE FOR THE LIBERIAN CONTEXT. WHILE THERE HAS BEEN PROGRESS WITH CLINICAL RESEARCH TRAINING IN THE COUNTRY TO DATE, CLINICAL RESEARCH IN LIBERIA STILL FACES MANY CHALLENGES, INCLUDING LIMITED FUNDING, A SHORTAGE OF TRAINED RESEARCHERS, AND A LACK OF ACCESS TO ADVANCED TECHNOLOGY AND RESOURCES. THE ADVANCING CLINICAL TRIALS ON HIV (ACTONHIV) IN LIBERIA COLLABORATION IS A PARTNERSHIP BETWEEN THE UNIVERSITY OF LIBERIA COLLEGE OF HEALTH SCIENCES (ULCHS) AND YALE UNIVERSITY TO DEVELOP AN HIV CLINICAL RESEARCH TRAINING PROGRAM THAT CENTERS THE LIBERIAN CONTEXT AND NEEDS TO ENSURE LONG-TERM SUSTAINABILITY AND ADVANCES ITS CAPACITY FOR LOCALLY LED CLINICAL TRIALS AND IMPLEMENTATION SCIENCE RESEARCH. THE ACTONHIV PROGRAM WILL ENHANCE LIBERIA'S HIV CLINICAL TRIALS CAPACITY BY REFINING THE COUNTRY'S HIV RESEARCH TRAINING AGENDA AS INFORMED BY PRE-IDENTIFIED GAPS AND PRIORITIES AND ESTABLISHING A LONG-TERM FORMAL HIV-RESEARCH- TRAINING COLLABORATIVE NETWORK BETWEEN YALE UNIVERSITY AND ULCHS AND SUPPORTED BY A REGIONAL PARTNER, JOS UNIVERSITY IN NIGERIA, TO STRENGTHEN SOUTH-SOUTH COLLABORATION FOR TRAINING. IT WILL ALSO CREATE A STRUCTURED HIV RESEARCH TRAINING PLAN FOR AN HIV-D43-FUNDING MECHANISM THAT MATCHES EXPERIENCED RESEARCHERS WITH MENTEES ALIGNED WITH THEIR HIV RESEARCH FOCUS AREA AND RESEARCH PHENOTYPE TO PRODUCE A DIVERSE, SKILLED, HIGHLY COMPETENT, MULTI-TIERED LIBERIAN HIV-RESEARCH TEAM. THIS WILL BE ACHIEVED BY ADVANCED RESEARCH TRAINING THAT WILL SUPPORT FELLOWS AND RESIDENT PHYSICIANS, AS WELL AS MID-CAREER FACULTY AT THE ULCHS, IN THEIR TRANSITION TO BECOMING (OR ADVANCEMENT AS) INVESTIGATORS. ADDITIONAL STRUCTURED TRAINING WILL AIM TO DEVELOP A CADRE OF SUPPORT STAFF INCLUDING RESEARCH NURSES AND REGULATORY SPECIALISTS TO FACILITATE ROBUST CLINICAL INVESTIGATION IN HIV PREVENTION AND CARE IN LIBERIA. TRAINING WILL BE INFORMED BY THE COMPREHENSIVE PLANNING AND LANDSCAPE ANALYSIS OF THE D71 ACTIVITIES, AND ENVISIONED PLANS INCLUDE RELEVANT CLINICAL RESEARCH-RELATED SHORT-MEDIUM TERM COURSES FOR THE FULL SPECTRUM OF TRAINEES AND LONG-TERM ADVANCED DEGREE PROGRAMS FOCUSED ON HIV RESEARCH (MPH, MSC OR PHD DEGREES) FOR PHYSICIANS AND ULCHS FACULTY AT ULCHS, YALE OR JOS UNIVERSITY.

Posted 5/8/25, 12:00 AM